The 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) Hilton Hotel, Prague, Czech Republic, May 13-16, 2010
CODHy 2010 Webcasting
This educational programme is supported by Bristol-Myers Squibb and AstraZeneca. The kidney and the gut provide new targets for oral antidiabetic therapy: progress in the clinical management of type 2 diabetes Selected Presentations from the Congress Scientific Program.   Beta-cell protection Animal studies M. Donath Switzerland Normalizing A1C – Efficacy and safety of new novel drugs R.A. DeFronzo USA Pharmacologic prevention of T2DM Pro R.A. DeFronzo USA Pharmacologic prevention of T2DM Con J. Tuomilehto Finland Metformin Failure: What is next? Incretins S. Del Prato, Italy ACCORD, ADVANCE and VADT G. Schernthaner Austria Hypoglycaemia and its potential contribution to fatal cardiac arrhythmias in T1D and T2D S. Heller UK The Heart in Diabetes A macrovascular disease D. Tschöpe Germany The Heart in Diabetes A microvascular disease M. Laakso Finland Vascular disease endothelial function and clinical implication and endothelium. Target for therapy A. Natali Italy